Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease?
about
CD30+ Lymphoproliferative Disorders of the Skin.Gemcitabine-associated CD8+ CD30+ pseudolymphoma.HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
P2860
Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease?
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Is CD30 (Ki-1) immunostaining ...... ker of advanced HIV-1 disease?
@en
Is CD30
@nl
type
label
Is CD30 (Ki-1) immunostaining ...... ker of advanced HIV-1 disease?
@en
Is CD30
@nl
prefLabel
Is CD30 (Ki-1) immunostaining ...... ker of advanced HIV-1 disease?
@en
Is CD30
@nl
P2093
P2860
P1476
Is CD30 (Ki-1) immunostaining ...... ker of advanced HIV-1 disease?
@en
P2093
Barrett TL
Skelton HG
Tomaszewski MM
P2860
P304
P356
10.1046/J.1365-2133.1998.02212.X
P407
P577
1998-05-01T00:00:00Z